DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
tirzepatide (Mounjaro) and nausea: incidence, timing, management, and when to escalate.
Peaks at dose escalation (especially 5 mg, 10 mg, 15 mg steps).
Slowed gastric emptying via GLP-1 and GIP receptor activity.
Hold dose if intolerable. Smaller meals. Ondansetron PRN.
Severe abdominal pain, bilious vomiting, dehydration.
Tirzepatide nausea profile is slightly different from semaglutide. Some patients who failed semaglutide tolerate tirzepatide better, and vice versa. The mechanism overlaps but is not identical.
Editorial summary, not medical advice. Incidence figures from FDA prescribing information and pivotal trial publications. Individual experience varies. Coordinate side effect management with your prescriber.